Clinical Trial Update: Clinical Study on the Efficacy and Safety of Multiple Oral Administrations of SHR2285 Tablets in Patients Undergoing Elective Total Knee Arthroplasty [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating SHR2285 tablets for prevention of venous thrombosis after total knee arthroplasty has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• SHR2285 (SHR2285)

Snippet

Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. | Conditions: Prevention of Venous Thrombosis After TKA | Phase 2 | Status: TERMINATED